BeiGeneius - Lymphoma management during the COVID-19 pandemic: New evidence-based insights and recommendations - BeiGene Medical Europe
 

BeiGeneius - Lymphoma management during the COVID-19 pandemic: New evidence-based insights and recommendations

 Back  View
BeiGeneius - Lymphoma management during the COVID-19 pandemic: New evidence-based insights and recommendations
 VIDEO   1:35:06   08/2021
 View

BeiGeneius - Lymphoma management during the COVID-19 pandemic: New evidence-based insights and recommendations

Thursday, July 29, 2021 | 17:00 - 18:30 (CEST)

 

Christian Buske

University Hospital of Ulm, Germany

 

Meletios A. Dimopoulos
National and Kapodistrian University of Athens School of Medicine, Greece

 

Wojciech Jurczak
Maria Skłodowska-Curie National Research Institute of Oncology, Poland

Rating

Rate this resource

Related resources

Challenges in the diagnosis, staging, and clinical work up of Waldenström’s macroglobulinemia (WM): A practical guide to current best practice The complete webcast.
Challenges in the diagnosis, staging, and clinical work up of Waldenström’s macroglobulinemia (WM): A practical guide to current best practice The complete webcast.
BeiGeneius - Initiation of treatment for Waldenström’s macroglobulinemia: Practical guidance for starting treatment and managing complications
BeiGeneius - Initiation of treatment for Waldenström’s macroglobulinemia: Practical guidance for starting treatment and managing complications
BeiGeneius - Next-generation BTK inhibitors for relapsed/refractory B-cell malignancies: What are the options and how do they compare?
BeiGeneius - Next-generation BTK inhibitors for relapsed/refractory B-cell malignancies: What are the options and how do they compare?
 Back